Trimetazidine protects against smoking-induced left ventricular remodeling via attenuating oxidative stress, apoptosis, and inflammation

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Zhou, Xiang ^a   Li, Chao ^b   Xu, Weiting ^a   Chen, Jianchang ^a  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE PEROXIDASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOCORTIN 5; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TRIMETAZIDINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HEART MUSCLE CELL; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; INFLAMMATION; MALE; MORPHOMETRICS; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

RATTUS; RATTUS NORVEGICUS;

EID: 84863665293     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040424     Document Type: Article

References (43)

1. Lakier JB, (1992) Smoking and cardiovascular disease. Am J Med 93: 8S-12S.
2. Burns DM, (2003) Epidemiology of smoking-induced cardiovascular disease. Prog Cardiovasc Dis 46: 11-29.
3. He J, Vupputuri S, Allen K, Prerost MR, Hughes J, et al. (1999) Passive smoking and the risk of coronary heart disease-a meta-analysis of epidemiologic studies. N Engl J Med 340: 920-926.
4. Teo KK, Ounpuu S, Hawken S, Pandey MR, Valentin V, et al. (2006) Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 368: 647-658.
5. Zhou X, Sheng Y, Yang R, Kong X, (2010) Nicotine promotes cardiomyocyte apoptosis via oxidative stress and altered apoptosis-related gene expression. Cardiology 115: 243-250.
6. Cohn JN, Ferrari R, Sharpe N, (2000) Cardiac remodelling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol 35: 569-582.
7. Castardeli E, Paiva SA, Matsubara BB, Matsubara LS, Minicucci MF, et al. (2005) Chronic cigarette smoke exposure results in cardiac remodeling and impaired ventricular function in rats. Arq Bras Cardiol 84: 320-324.
8. Castardeli E, Duarte DR, Minicucci MF, Azevedo PS, Matsubara BB, et al. (2007) Tobacco smoke-induces left ventricular remodeling is not associated with metalloproteinase-2 or-9 activation. Eur J Heart Fail 9: 1081-1085.
9. Gu L, Pandey V, Geenen DL, Chowdhury SA, Piano MR, (2008) Cigarette smoke-induced left ventricular remodelling is associated with activation of mitogen-activated protein kinases. Eur J Heart Fail 10: 1057-1064.
10. Thrainsdottir IS, von Bibra H, Malmberg K, Rydén L, (2004) Effects of trimetazidine on left ventricular function in patients with type 2 diabetes and heart failure. J Cardiovasc Pharmacol 44: 101-108.
11. Fragasso G, Palloshi A, Puccetti P, Silipigni C, Rossodivita A, et al. (2006) A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure. J Am Coll Cardiol 48: 992-998.
12. Fragasso G, Perseghin G, De Cobelli F, Esposito A, Palloshi A, et al. (2006) Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure. Eur Heart J 27: 942-948.
13. Fantini E, Demaison L, Sentex E, Grynberg A, Athias P, (1994) Some biochemical aspects of the protective effect of trimetazidine on rat cardiomyocytes during hypoxia and reoxygenation. J Mol Cell Cardiol 26: 949-958.
14. Bertomeu-Gonzalez V, Bouzas-Mosquera A, Kaski JC, (2006) Role of trimetazidine in management of ischemic cardiomyopathy. Am J Cardiol 98: 19J-24J.
15. Maridonneau-Parini I, Harpey C, (1985) Effects of trimetazidine on membrane damage induced by oxygen free radicals in human red cells. Br J Clin Pharmacol 20: 148-151.
16. Khan M, Meduru S, Mostafa M, Khan S, Hideg K, et al. (2010) Trimetazidine, administered at the onset of reperfusion, ameliorates myocardial dysfunction and injury by activation of p38 mitogen-activated protein kinase and Akt signaling. J Pharmacol Exp Ther 333: 421-429.
17. Park KH, Park WJ, Kim MK, Park DW, Park JH, et al. (2010) Effects of trimetazidine on endothelial dysfunction after sheath injury of radial artery. Am J Cardiol 105: 1723-1727.
18. Wang XD, Liu C, Bronson RT, Smith DE, Krinsky NI, et al. (1999) Retinoid signaling and activator protein-1 expression in ferrets given b-carotene supplements and exposure to cigarette smoke. J Natl Cancer Inst 91: 60-66.
19. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, et al. (1989) Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2: 358-367.
20. Ohkawa H, Ohishi N, Yagi K, (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351-358.
21. Sun Y, Oberley LW, Li Y, (1988) A simple method for clinical assay of superoxide dismutase. Clin Chem 34: 497-500.
22. Paglia DE, Valentine WN, (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70: 158-169.
23. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
24. Haustein KO, (1999) Smoking tobacco, microcirculatory changes and the role of nicotine. Int J Clin Pharmacol Ther 37: 76-85.
25. Heckbert SR, Post W, Pearson GD, Arnett DK, Gomes AS, et al. (2006) Traditional cardiovascular risk factors in relation to left ventricular mass, volume, and systolic function by cardiac magnetic resonance imaging: the Multiethnic Study of Atherosclerosis. JACC 48: 2285-2292.
26. Rosen BD, Saad MF, Shea S, Nasir K, Edvardsen T, et al. (2006) Hypertension and smoking are associated with reduced regional left ventricular function in asymptomatic individuals. JACC 47: 1150-1158.
27. Di Napoli P, Taccardi AA, Barsotti A, (2005) Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischaemic dilated cardiomyopathy. Heart 91: 161-165.
28. Hori M, Nishida K, (2009) Oxidative stress and left ventricular remodelling after myocardial infarction. Cardiovasc Res 81: 457-464.
29. Kameda K, Matsunaga T, Abe N, Hanada H, Ishizaka H, et al. (2003) Correlation of oxidative stress with activity of matrix metalloproteinase in patients with coronary artery disease. Possible role for left ventricular remodelling. Eur Heart J 24: 2180-2185.
30. Lord KC, Shenouda SK, McIlwain E, Charalampidis D, Lucchesi PA, et al. (2010) Oxidative stress contributes to methamphetamine-induced left ventricular dysfunction. Cardiovasc Res 87: 111-118.
31. Murdoch CE, Zhang M, Cave AC, Shah AM, (2006) NADPH oxidasedependent redox signalling in cardiac hypertrophy, remodelling and failure. Cardiovasc Res 71: 208-215.
32. Sawyer DB, Siwik DA, Xiao L, Pimentel DR, Singh K, et al. (2002) Role of oxidative stress in myocardial hypertrophy and failure. J Mol Cell Cardiol 34: 379-388.
33. Giordano FJ, (2005) Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 115: 500-508.
34. Zima AV, Blatter LA, (2006) Redox regulation of cardiac calcium channels and transporters. Cardiovasc Res 71: 310-321.
35. Sabri A, Hughie HH, Lucchesi PA, (2003) Regulation of hypertrophic and apoptotic signaling pathways by reactive oxygen species in cardiac myocytes. Antioxid Redox Signal 5: 731-740.
36. Cheng TH, Cheng PY, Shih NL, Chen IB, Wang DL, et al. (2003) Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts. J Am Coll Cardiol 42: 1845-1854.
37. Siwik DA, Pagano PJ, Colucci WS, (2001) Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. Am J Physiol Cell Physiol 280: C53-C60.
38. Chandrashekhar Y, (2005) Role of apoptosis in ventricular remodeling. Curr Heart Fail Rep 2: 18-22.
39. Abbate A, Biondi-Zoccai GG, Baldi A, (2002) Pathophysiologic role of myocardial apoptosis in post-infarction left ventricular remodeling. J Cell Physiol 193: 145-153.
40. Ibe W, Saraste A, Lindemann S, Bruder S, Buerke M, et al. (2007) Cardiomyocyte apoptosis is related to left ventricular dysfunction and remodelling in dilated cardiomyopathy, but is not affected by growth hormone treatment. Eur J Heart Fail 9: 160-167.
41. Abbate A, Biondi-Zoccai GG, Bussani R, Dobrina A, Camilot D, et al. (2003) Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure. J Am Coll Cardiol 41: 753-760.
42. Nian M, Lee P, Khaper N, Liu P, (2004) Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 94: 1543-1553.
43. Bozkurt B, Kribbs SB, Clubb FJ Jr, Michael LH, Didenko VV, et al. (1998) Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation 97: 1382-1391.